Back to results
US 2022/0008367 A1Published application
Methods of treating idiopathic hypersomnia
AssigneeJazz Pharmaceuticals Ireland Limited
InventorsFranck SKOBIERANDA, Dan CHEN, Amanda Leigh STERKEL, Cuiping CHEN, Patricia CHANDLER
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to methods of treating idiopathic hypersomnia with oxybate, preferably a mixture of salts of oxybate (a mixed salt oxybate).
Claims48
A method of treating idiopathic hypersomnia in a patient in need thereof, the method comprising:
- administering a therapeutically effective amount of a mixed salt oxybate to the patient.
(canceled)
(canceled)
-27. (canceled)
-58. (canceled)
(canceled)
A method of treating idiopathic hypersomnia in a patient in need thereof, the method comprising:
- administering a therapeutically effective amount of a mixed salt oxybate to the patient once per day,
- wherein the mixed salt oxybate comprises about 5%-40% sodium oxybate, about 10%-40% potassium oxybate, about 5%-30% magnesium oxybate, and about 20%-80% of calcium oxybate (% mol. eq.).
Dependencies are inferred from the claim text.